Richard Weaver will be joining the panel at the ON Helix Welcome Reception on the 12th July in Cambridge.
Numerous industrial sponsors, large and small, now rely upon CROs to undertake much of their early stage R&D. The panel will discuss how the divergent CRO sector can work with academia, technology transfer offices and early stage companies in order to strengthen drug discovery programmes and secure grant, investment, collaboration or partnering deals.
ON Helix is the One Nucleus conference for the life sciences sector, and is aimed at informing delegates on how to turn early stage inventions and ideas into innovative health treatments.
The welcome reception takes place the day before the main ON Helix conference. For more information, click here.